Arama Sonuçları - Simon Portsmouth
- Gösterilen 1 - 9 sonuçlar arası kayıtlar. 9
-
1
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma Yazar: Simon Portsmouth, Justin Stebbing, Jas Gill, Sundhiya Mandalia, Mark Bower, Mark Nelson, Mark Bower, Brian Gazzard
Baskı/Yayın Bilgisi 2003Artigo -
2
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase–Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies Yazar: Jean Francois Timsit, Mical Paul, Ryan K. Shields, Roger Echols, Takamichi Baba, Yoshinori Yamano, Simon Portsmouth
Baskı/Yayın Bilgisi 2022Artigo -
3
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program Yazar: Michael J. Satlin, Patricia J. Simner, Christine M Slover, Yoshinori Yamano, Tsutae Den Nagata, Simon Portsmouth
Baskı/Yayın Bilgisi 2023Artigo -
4
An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals Yazar: Mark Nelson, Simon Portsmouth, Justin Stebbing, Mark Atkins, A. Barr, Gail Matthews, Deenan Pillay, MJ Fisher, Mark Bower, Brian Gazzard
Baskı/Yayın Bilgisi 2003Artigo -
5
Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia Yazar: Takayuki Katsube, David P. Nicolau, Keith A. Rodvold, Richard G. Wunderink, Roger Echols, Yuko Matsunaga, Anju Menon, Simon Portsmouth, Toshihiro Wajima
Baskı/Yayın Bilgisi 2021Artigo -
6
Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza Yazar: Takeki Uehara, Frederick G. Hayden, Keiko Kawaguchi, Shinya Omoto, Aeron C. Hurt, Menno D. de Jong, Nobuo Hirotsu, Norio Sugaya, Nelson Lee, Keiko Baba, Takao Shishido, Kenji J. Tsuchiya, Simon Portsmouth, Hiroshi Kida
Baskı/Yayın Bilgisi 2019Artigo -
7
Deep V3 Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of Maraviroc Yazar: Luke C. Swenson, Theresa Mo, Winnie Dong, Xiaoyin Zhong, Conan K. Woods, Alexander Thielen, Mark A. Jensen, David J. H. F. Knapp, Douglass Chapman, Simon Portsmouth, Marilyn Lewis, Ian James, Jayvant Heera, Hernán Valdez, P. Richard Harrigan
Baskı/Yayın Bilgisi 2011Artigo -
8
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents Yazar: Frederick G. Hayden, Norio Sugaya, Nobuo Hirotsu, Nelson Lee, Menno D. de Jong, Aeron C. Hurt, Tadashi Ishida, Hisakuni Sekino, Kota Yamada, Simon Portsmouth, Keiko Kawaguchi, Takao Shishido, Masatsugu Arai, Kenji J. Tsuchiya, Takeki Uehara, Akira Watanabe
Baskı/Yayın Bilgisi 2018Artigo -
9
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial Yazar: Anne F. Luetkemeyer, Kara W. Chew, Stuart R. Lacey, Michael D. Hughes, Linda J. Harrison, Eric S. Daar, Joseph J. Eron, Courtney V. Fletcher, Alexander L. Greninger, Diane Hessinger, Jonathan Z. Li, D. Mailhot, David A. Wohl, Methee Chayakulkeeree, J.L. Mendoza, Polina Elistratova, O. N. Makinde, Gareth Morgan, Simon Portsmouth, Takeki Uehara, Davey M. Smith, Judith S. Currier
Baskı/Yayın Bilgisi 2025Artigo
Arama Araçları:
İlgili Konular
Medicine
Internal medicine
Biology
Viral load
Virus
Antibiotics
Confidence interval
Gastroenterology
Microbiology
Virology
Adverse effect
Alternative medicine
Antiretroviral therapy
Bacteria
Clinical endpoint
Coronavirus disease 2019 (COVID-19)
Disease
Genetics
Human immunodeficiency virus (HIV)
Immunology
Infectious disease (medical specialty)
Influenza A virus
Oseltamivir
Pathology
Placebo
Pseudomonas aeruginosa
Randomized controlled trial
Regimen
Reverse-transcriptase inhibitor
Seroconversion